A Novel, Potent and Non-addictive Analgesic of Combinations for Knee Replacement Moderate to Severe Pain Management

NCT05842733 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain, Postoperative

Interventions

DRUG: Naldebain
DRUG: SafeTynadol
DRUG: Naldebain + SafeTynadol

Sponsor

Sinew Pharma Inc.